RxDoctor Payments Data

Melvyn Acosta, MD

Gastroenterology · San Juan, PRNPI 1811993660

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. E.r. Squibb & Sons, L.L.C. accounts for 71.8% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for gastroenterology clinicians in PR, where the typical reported total is $1,676.

$58in general payments, 2019–2025

Across 3 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$42
  • Sanofi$16
$371,431in research payments, 2019–2025

Across 79 payments — averaging $4701.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$319K
  • Eli Lilly$52K

What the payments were for

  • Food & beverage$58100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.2$42
Sanofi1$16

How this compares

$58 in reported general payments places this provider in the 5th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$17,835
Medicare patients
57
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate41$8,227
SutabSod Sulf/Pot Chloride/Mag Sulf25$4,188
SuprepSodium, Potassium,mag Sulfates30$3,518
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl115$2,829
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates13$962
Famotidine112$907
Pantoprazole Sodium93$744
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl15$406
Dicyclomine Hcl21$212
Ciprofloxacin Hcl20$206
Flumazenil24$187
Naloxone Hcl15$163
Midazolam Hcl45$121
Metoclopramide Hcl14$95
Midazolam HclMidazolam Hcl/Pf27$75

Paid to pharmacies, not to this prescriber.

Other gastroenterology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →